Navigating CGT Cold Chain Challenges: Expert Perspectives And Implications On Scaling Storage Solutions To Meet Future Demand

While oncologists recognize cell and gene therapies (CGTs) as pivotal innovations, nearly two-thirds express concerns about patient access, and over half see a need for process optimization to boost operational efficiency. This poster reveals findings from a survey of 124 oncologists and 19 CGT experts, who identified cold chain storage, warehousing, and logistics as top concerns in the CGT supply chain. Despite confidence in current product intake management, experts highlight storage capacity as a critical challenge.
Explore the critical insights and the implications for scaling solutions to meet future demand. Download the poster to learn more.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.